1. Haahtela Т, Larsson K, Вопгпг S. Epidemiology of Asthma, allergy and bronchial hyperresponsiveness in sports. Eur Res Monograph 2005; 33 (10): 1–3.
2. Palange R, Brusasco V, Delgado L, Del Giacco S. Exercise and airway physiology: interactions with immune and allergic responses. Eur Res Monograph 2005; 33 (10): 10–5.
3. Bjermer L, Anderson SD. Bronchial hyperresponsiveness in athletes: mechanisms for development. Eur Res Monograph 2005; 33 (10): 19–29.
4. Anderson SD, Brusasco V, Haahtela Т, Popov T. Criteria for diagnosis of asthma, EIB and AHR for athletes: lessons from the Olympic Games. Eur Res Monograph 2005; 33 (10): 48–60.
5. Larsson K, Carlsen K-H, Bonini S. Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction. Eur Res Monograph 2005; 33 (10): 73–83.
6. Van Cauwenberge P, Palange P, Canonica GW. Prevention: educational issues and recommendations for early recognition. Eur Res Monograph 2005; 33 (10): 89–98.
7. Wilber RL, Rundell KW, Szmedra L et al. Incidence of exercise-induced bronchospasm in Olympic Winter sport athletes. Med Sci Sports Exerc 2000; 32: 732–7.
8. Lumme A, Haahtela Т, Ounap J et al. Airway inflammation, bronchial hyperresponsiveness, and asthma in elite ice hockey players. Eur Res J 2003; 22: 113–7.
9. Karjalainen EM, Laitinen A, Sue-Chu M et al. A. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Res Grit Care Med 2000; 161: 2086–91.
10. Kosunen TU, Hook-Nikanne J, Salomaa A et al. Increase of allergenspecific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to helicobacter pylori infections. Clin Exp Allergy 2002; 32: 373–8.
11. Krause Т, Koch A, Friborg J et al. Frequency of atopy in the arctic in 1987 and 1998. Lancet 2002; 360: 691–2.
12. Nieman DC, Johanssen LM, Lee JW, Arabatzis K. Infectious episodes in runners before and after the Los Angeles Marathon. J Sports Med Phys Fitness 1990; 30: 316–28.
13. Quanjer PH, Tammeling GJ, Pedersen OF et al. Lung volumes and forced ventilatory flows. Eur Res J 1993; 6: 5–40.
14. Simons FE, Gerstner TV, Cheang MS. Tolerance to the bronchop-rotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997; 99: 655–9.
15. Nelson JA, Strauss L, Skowronski M et al. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med 1998; 339: 141–6.
16. Waalkens HJ, van Essen-Zandvliet EE, Gernlsen J et al. The effect of an inhaled corticosteroid (bu-desonide) on exercise-induced asthma in children. Dutch CNSLD Study Group. Eur Res J 1993; 6: 652–6.
17. Peroni DG, Piacentini GL, Ress M et al. Time efficacy of a single dose of montelukast on exercise-induced asthma in children. Pediatr Allergy Immunol 2002; 13: 434–7.
18. Laursen LC, Johannesson N, Weeke B. Effects of enprofylline and theofylline on exercise-induced asthma. Allergy 1985; 40: 506–9.
19. Baki A, Orhan F. The effect of loratadine in exercise-induced asthma. Arch Dis Child 2002; 86: 38–9.
20. Magnussen H, Nowak D, Wifbicke W. Effect of inhaled ipratropium bromide on the airway response to methaholine, histamine, and exercise in patients with mild bronchial asthma. Respiration 1992; 59: 42–7.
21. Patel KR, Tullel WM. Comparison of two calcium antagonists verapamil and gallopamil (D-600), in exercise-induced asthma. Eur J Res Dis 1985; 67: 269–71.